Updated Oct 28, 2026 · 12:56 UTC
IDXXIdexx Laboratories, Inc.
Health Care · United States · XNAS · in vitro & in vivo diagnostic substances
$556.13−1.57%last session · market early-hours
Market cap
$43.81b
real-world
Tokenized
$0
<0.001% of the asset
Avg token price
$549.05
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
IDXX · Price
EarningsNasdaq’s earnings calendar
Next earnings
Nov 2
before the open · Sep 2026 quarter · EPS forecast $3.71 (6 analysts)
Last earnings, Aug 4
$4.27 EPS
+8.1% vs $3.95 forecast · Jun 2026 quarter
Real marketIdexx Laboratories Inc
Last close
$561.25
Oct 27
Traded on Oct 27
$275.0m
Price now
$556.13
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions1 token from 1 issuer
wIDXXxBacked Assets——Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$4.55b
+13% YoY
Operating income
$1.46b
32% margin · +16% YoY
Net income
$1.14b
25% margin · +16% YoY
Gross margin
62%
+0.9 pts YoY
EPS, diluted
$14.37
+18% YoY
Diluted shares
79m
−2% YoY
Cash and balance sheet
Free cash flow
$1.25b
28% of revenue · 2.9% yield
Net debt
$252.9m
$196.9m cash and securities, $449.9m debt
Quarterly
RevenueNet income
Valuation today’s market cap $43.81b · enterprise value $44.07b
P/E
38.4×
EV / sales
9.7×
EV / op. income
30.2×